David Y Horwitz

US Patent:

8439837, May 14, 2013

Filed:

Oct 30, 2007

Appl. No.:

11/928560

Inventors:

Sharbel E. Noujaim - Menlo Park CA, US
David Horwitz - Los Altos CA, US
Manoj Sharma - Milpitas CA, US
Joseph Marhoul - San Jose CA, US

Assignee:

LifeScan, Inc. - Milpitas CA

International Classification:

A61B 51/14532
A61B 51/14503

US Classification:

600365, 600373

Abstract:

The present invention is directed to a method of reducing false readings in a hypoglycemic detector that includes establishing a predetermined hypoglycemic threshold, a predetermined critical threshold, a predetermined rate of change in glucose concentration where the predetermined critical threshold is below the predetermined hypoglycemic threshold. A first sampling rate is then calculated based upon said predetermined hypoglycemic threshold, said predetermined critical threshold, and said predetermined rate of change in glucose concentration.

US Patent:

20100016700, Jan 21, 2010

Filed:

Jul 17, 2009

Appl. No.:

12/505007

Inventors:

Zara Sieh - Pleasanton CA, US
David Horwitz - Los Altos CA, US
David Price - Pleasanton CA, US
Peter Krulevitch - Pleasanton CA, US
Donna Savage - Rolling Hills Estates CA, US
Robert Shartle - Arnold CA, US

Assignee:

LifeScan, Inc. - Milpitas CA

International Classification:

A61B 5/00
G06F 3/048
H04L 9/32
G08B 1/08
G06F 15/16
G06N 5/02

US Classification:

600365, 715810, 726 16, 34053912, 709202, 709206, 706 54

Abstract:

Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.

US Patent:

20100256047, Oct 7, 2010

Filed:

Apr 3, 2009

Appl. No.:

12/417875

Inventors:

Zara Sieh - Pleasanton CA, US
David Horwitz - Los Altos CA, US
David Price - Pleasanton CA, US
Peter Krulevitch - Pleasanton CA, US
Donna Savage - Rolling Hills Estates CA, US
Robert Shartle - Arnold CA, US

Assignee:

LifeScan, Inc. - Milpitas CA

International Classification:

A61K 38/28
A61P 3/10
G06F 19/00

US Classification:

514 3, 702 19

Abstract:

A method for measuring and managing an analyte (e.g., blood glucose) in a bodily fluid includes storing a therapeutic administration protocol in a memory module of an analyte measurement and management device and measuring the analyte in the bodily fluid sample using an analyte measurement module of the device. The method also includes calculating, with a processor module of the device, a recommended therapeutic agent dosage (for example, an insulin dosage) and a recommended administration time for user-activated delivery of the dosage by employing the therapeutic administration protocol. The method further includes displaying the recommended therapeutic agent dosage and administration time to a user on a visual display of the device, delivering a therapeutic agent dosage to the user via a user-activated therapeutic agent delivery device, and detecting the user-activated administration of the therapeutic agent using a delivery device communication module of the device. In addition, the method includes communicating the aforementioned detection to the processor module and/or memory module using the delivery device communication module. The method employs analyte measurement, memory, processor, and delivery device modules, as well as a visual display, and user interface that are integrated as a single hand-held unit.